https://medicaex.com/businesswire/virpax-pharmaceuticals-reports-2022-third-quarter-results-2/ 2022-11-09T14:12:16+00:00 https://medicaex.com/wp-content/uploads/2022/11/New_Logo-fTlNRH.jpeg https://medicaex.com/businesswire/keystone-bio-adds-significant-scientific-leadership-with-appointment-of-medical-advisor-and-new-scientific-advisory-board-members/ 2022-11-09T14:12:16+00:00 https://medicaex.com/wp-content/uploads/2022/11/KB_logo-5qyDCq.jpeg https://medicaex.com/businesswire/precision-biologics-to-deliver-poster-presentations-on-clinical-and-scientific-programs-at-society-for-immunotherapy-of-cancer-sitc-37th-annual-meeting-2/ 2022-11-09T14:12:16+00:00 https://medicaex.com/businesswire/aim-immunotech-announces-corporate-governance-enhancements-2/ 2022-11-09T14:12:16+00:00 https://medicaex.com/businesswire/fresenius-kabi-announces-2022-inductees-to-blood-donation-hall-of-fame-3/ 2022-11-09T14:12:16+00:00 https://medicaex.com/wp-content/uploads/2022/11/fsk_dhof_video_compilation_101422_28129-DBOjwg.jpeg https://medicaex.com/businesswire/a-new-medcase-study-shows-that-within-health-organizations-only-1-in-3-clinicians-had-access-to-psychological-debriefings-for-emotionally-challenging-cases-2/ 2022-11-09T14:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/medcase_logo_square_transparent-gC0jmp.jpeg https://medicaex.com/businesswire/oura-introduces-three-new-c-suite-leaders/ 2022-11-09T14:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/Oura_Logo_Wordmark_Black_28529-9mcWLk.jpeg https://medicaex.com/businesswire/whoop-identifies-novel-pregnancy-digital-biomarker-to-screen-for-premature-birth/ 2022-11-09T14:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/WHOOP_Logo_R_Black_28129_28129-TJjmLI.jpeg https://medicaex.com/businesswire/global-flat-panel-detectors-market-analysis-to-2029-players-include-hamamatsu-photonics-vieworks-analogic-teledyne-technologies-and-fujifilm-holdings-researchandmarkets-com/ 2022-11-09T14:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-MVJYWM.jpeg https://medicaex.com/businesswire/saranas-announces-over-1200-patients-treated-with-the-early-bird-bleed-monitoring-system/ 2022-11-09T14:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/Saranas_logo_RGB-Ov4SGP.jpeg https://medicaex.com/businesswire/health-systems-collaborate-with-nahq-to-standardize-competencies-2/ 2022-11-09T14:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/NAHQ_Logo-9B5Jar.jpeg https://medicaex.com/businesswire/world-first-dual-wave-rf-micro-needling-system-sylfirm-x-is-recognized-by-top-us-aesthetic-dermatologists/ 2022-11-09T14:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/5Bphoto5D_Top_US_board-certified_plastic_surgeons_were_invited_to_Moonlight_Sylfirm_X_Global_Symposium_20222C_at_Grand_Mercure_Hotel2C_Seoul-lMgNMv.jpeg https://medicaex.com/businesswire/fresenius-kabi-announces-2022-inductees-to-blood-donation-hall-of-fame-2/ 2022-11-09T14:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/fsk_dhof_video_compilation_101422_28129-2HQ1hK.jpeg https://medicaex.com/businesswire/fresenius-kabi-announces-2022-inductees-to-blood-donation-hall-of-fame/ 2022-11-09T14:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/fsk_dhof_video_compilation_101422_28129-wotGth.jpeg https://medicaex.com/businesswire/health-systems-collaborate-with-nahq-to-standardize-competencies/ 2022-11-09T14:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/NAHQ_Logo-tMimv1.jpeg https://medicaex.com/businesswire/mohawk-valley-health-system-launches-integrated-specialty-pharmacy-and-disease-management-services-for-patients-with-chronic-and-complex-conditions/ 2022-11-09T14:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Trellis_Rx_Logo_-_CPS_Tagline_-_Full_Color-KzwxcV.jpeg https://medicaex.com/businesswire/precision-biologics-to-deliver-poster-presentations-on-clinical-and-scientific-programs-at-society-for-immunotherapy-of-cancer-sitc-37th-annual-meeting/ 2022-11-09T14:12:06+00:00 https://medicaex.com/businesswire/eikonoklastes-therapeutics-receives-fda-orphan-drug-designation-for-1st-in-class-treatment-of-amyotrophic-lateral-sclerosis-als/ 2022-11-09T14:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/eikonoklastes_Logo_Full_Color_28229-Z0oJvO.jpeg https://medicaex.com/businesswire/aim-immunotech-announces-corporate-governance-enhancements/ 2022-11-09T14:12:06+00:00 https://medicaex.com/businesswire/virpax-pharmaceuticals-reports-2022-third-quarter-results/ 2022-11-09T14:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/New_Logo-qS8Rx7.jpeg https://medicaex.com/businesswire/a-new-medcase-study-shows-that-within-health-organizations-only-1-in-3-clinicians-had-access-to-psychological-debriefings-for-emotionally-challenging-cases/ 2022-11-09T14:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/medcase_logo_square_transparent-TTQw9c.jpeg https://medicaex.com/businesswire/arrowhead-sells-royalty-interest-in-olpasiran-to-royalty-pharma-for-250-million-and-future-milestones-2/ 2022-11-09T13:12:16+00:00 https://medicaex.com/wp-content/uploads/2022/11/ah_logo_cmyk-UjBCkb.jpeg https://medicaex.com/businesswire/north-america-genotyping-market-report-2022-use-of-genotyping-in-drug-development-for-genetic-and-rare-diseases-drives-growth-researchandmarkets-com-2/ 2022-11-09T13:12:16+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-hSuIhI.jpeg https://medicaex.com/businesswire/rapid-ich-receives-new-fda-clearance-with-highest-sensitivity-and-specificity-on-the-market-2/ 2022-11-09T13:12:16+00:00 https://medicaex.com/wp-content/uploads/2022/11/rapid-AI-logo-brIyO1.jpeg https://medicaex.com/businesswire/vertex-to-participate-in-upcoming-investor-conferences-2/ 2022-11-09T13:12:16+00:00 https://medicaex.com/wp-content/uploads/2022/11/Vertex_Logo_colorRGB-DcaSYM.jpeg https://medicaex.com/businesswire/alnylam-to-webcast-presentations-at-upcoming-november-investor-conferences/ 2022-11-09T13:12:16+00:00 https://medicaex.com/wp-content/uploads/2022/11/Alnylam_Corporate_Logo-LtHRCU.jpeg https://medicaex.com/businesswire/elevance-health-to-acquire-bioplus-2/ 2022-11-09T13:12:13+00:00 https://medicaex.com/businesswire/twill-deepens-telebehavioral-health-offering-with-e-psychiatry-partnership-2/ 2022-11-09T13:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/Twill_Spacesuit_Orange-ZIC7uJ.jpeg https://medicaex.com/businesswire/endra-life-sciences-to-report-third-quarter-2022-financial-results-on-november-14-2022-2/ 2022-11-09T13:12:13+00:00 https://medicaex.com/businesswire/ambrx-announces-novocodexs-dosing-of-first-patient-with-arx305-ambrxs-investigational-antibody-drug-conjugate-targeting-cd70/ 2022-11-09T13:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/Ambrx_Logo-74qhdd.jpeg https://medicaex.com/businesswire/veradigm-ehr-achieves-2015-onc-health-it-update-certification-2/ 2022-11-09T13:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Allscripts-Logo-oTI88q.jpeg https://medicaex.com/businesswire/global-veterinary-ultrasound-market-report-2022-rise-in-the-companion-animal-population-and-rising-healthcare-expenditure-on-companion-animals-driving-growth-researchandmarkets-com/ 2022-11-09T13:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-9RoO64.jpeg https://medicaex.com/businesswire/rapid-ich-receives-new-fda-clearance-with-highest-sensitivity-and-specificity-on-the-market/ 2022-11-09T13:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/rapid-AI-logo-B4N1DU.jpeg https://medicaex.com/businesswire/endra-life-sciences-to-report-third-quarter-2022-financial-results-on-november-14-2022/ 2022-11-09T13:12:10+00:00 https://medicaex.com/businesswire/lensar-reports-third-quarter-2022-financial-results-and-provides-business-update/ 2022-11-09T13:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/LNSR_Logo-F60Pbg.jpeg https://medicaex.com/businesswire/surmodics-reports-fourth-quarter-and-fiscal-year-2022-financial-results-introduces-fiscal-year-2023-financial-guidance/ 2022-11-09T13:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/MicrosoftTeams-image-kTOoaR.jpeg https://medicaex.com/businesswire/the-worldwide-endoluminal-suturing-devices-industry-is-projected-to-reach-139-million-by-2027-researchandmarkets-com/ 2022-11-09T13:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-0ASPyd.jpeg https://medicaex.com/businesswire/henry-schein-to-present-at-upcoming-investor-conferences/ 2022-11-09T13:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/HenrySchein_2000x374-l5i9x3.jpeg https://medicaex.com/businesswire/arrowhead-sells-royalty-interest-in-olpasiran-to-royalty-pharma-for-250-million-and-future-milestones/ 2022-11-09T13:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/ah_logo_cmyk-N5wZ5n.jpeg https://medicaex.com/businesswire/north-america-genotyping-market-report-2022-use-of-genotyping-in-drug-development-for-genetic-and-rare-diseases-drives-growth-researchandmarkets-com/ 2022-11-09T13:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-XmakwF.jpeg https://medicaex.com/businesswire/veradigm-ehr-achieves-2015-onc-health-it-update-certification/ 2022-11-09T13:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Allscripts-Logo-XV7HHz.jpeg https://medicaex.com/businesswire/elevance-health-to-acquire-bioplus/ 2022-11-09T13:12:05+00:00 https://medicaex.com/businesswire/vertex-to-participate-in-upcoming-investor-conferences/ 2022-11-09T13:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Vertex_Logo_colorRGB-NzBbtJ.jpeg https://medicaex.com/businesswire/twill-deepens-telebehavioral-health-offering-with-e-psychiatry-partnership/ 2022-11-09T13:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/Twill_Spacesuit_Orange-shYHSo.jpeg https://medicaex.com/businesswire/global-pharmacy-benefit-manager-software-market-2022-increasing-demand-for-patient-care-and-disease-management-drive-growth-researchandmarkets-com/ 2022-11-09T13:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-S4SBAz.jpeg https://medicaex.com/businesswire/rockwell-medical-reacquires-distribution-rights-for-its-hemodialysis-concentrates-business-from-baxter-4/ 2022-11-09T11:12:16+00:00 https://medicaex.com/wp-content/uploads/2022/11/Rockwell_Medical_-_logo-brV4om.jpeg https://medicaex.com/businesswire/nanostring-and-abcam-expand-collaboration-to-advance-spatial-multiomics-research/ 2022-11-09T11:12:16+00:00 https://medicaex.com/wp-content/uploads/2022/11/4891105_NSTG_logo_for_Yahoo-4FPqRH.jpeg https://medicaex.com/businesswire/rockwell-medical-reacquires-distribution-rights-for-its-hemodialysis-concentrates-business-from-baxter-3/ 2022-11-09T11:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/Rockwell_Medical_-_logo-V1lXhq.jpeg https://medicaex.com/businesswire/rockwell-medical-reacquires-distribution-rights-for-its-hemodialysis-concentrates-business-from-baxter-2/ 2022-11-09T11:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Rockwell_Medical_-_logo-FOit8d.jpeg https://medicaex.com/businesswire/rockwell-medical-reacquires-distribution-rights-for-its-hemodialysis-concentrates-business-from-baxter/ 2022-11-09T11:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Rockwell_Medical_-_logo-BrhkgB.jpeg https://medicaex.com/businesswire/dna-script-strengthens-its-management-team-with-the-appointment-of-bruno-poddevin-as-senior-vice-president-of-business-and-corporate-development-3/ 2022-11-09T08:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/DNA_Script_Logo-LxqA55.jpeg https://medicaex.com/businesswire/tilt-biotherapeutics-announces-boston-office-opening-as-it-expands-its-clinical-trials-in-the-us-2/ 2022-11-09T08:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/TILT_logo-ZAHmCB.jpeg https://medicaex.com/businesswire/valbiotis-successfully-completes-a-fundraise-of-9-7-million-euros-2/ 2022-11-09T08:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/LOGO-NOIR-C4uH3A.jpeg https://medicaex.com/businesswire/dna-script-strengthens-its-management-team-with-the-appointment-of-bruno-poddevin-as-senior-vice-president-of-business-and-corporate-development-2/ 2022-11-09T08:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/DNA_Script_Logo-TQIooT.jpeg https://medicaex.com/businesswire/ka-imagings-reveal-35c-receives-ce-mark-certificate/ 2022-11-09T08:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Standard-Color-d28zay.jpeg https://medicaex.com/businesswire/dna-script-strengthens-its-management-team-with-the-appointment-of-bruno-poddevin-as-senior-vice-president-of-business-and-corporate-development/ 2022-11-09T08:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/DNA_Script_Logo-K9XPUF.jpeg https://medicaex.com/businesswire/tilt-biotherapeutics-announces-boston-office-opening-as-it-expands-its-clinical-trials-in-the-us/ 2022-11-09T08:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/TILT_logo-DYKt3a.jpeg https://medicaex.com/businesswire/valbiotis-successfully-completes-a-fundraise-of-9-7-million-euros/ 2022-11-09T08:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/LOGO-NOIR-J1MrWz.jpeg https://medicaex.com/businesswire/beckley-psytech-announces-first-participant-dosed-in-phase-i-trial-of-ele-101-a-novel-intravenous-formulation-of-psilocin-2/ 2022-11-09T07:12:14+00:00 https://medicaex.com/businesswire/sensorion-will-attend-in-person-the-jefferies-london-healthcare-conference-3/ 2022-11-09T07:12:14+00:00 https://medicaex.com/businesswire/sensorion-will-attend-in-person-the-jefferies-london-healthcare-conference-2/ 2022-11-09T07:12:10+00:00 https://medicaex.com/businesswire/beckley-psytech-announces-first-participant-dosed-in-phase-i-trial-of-ele-101-a-novel-intravenous-formulation-of-psilocin/ 2022-11-09T07:12:06+00:00 https://medicaex.com/businesswire/sensorion-will-attend-in-person-the-jefferies-london-healthcare-conference/ 2022-11-09T07:12:06+00:00 https://medicaex.com/businesswire/biomebank-announces-world-first-regulatory-approval-for-donor-derived-microbiome-drug-2/ 2022-11-09T06:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/BiomeBank-Logo-Horizontal-Colour-ziNoPt.jpeg https://medicaex.com/businesswire/onivyde-regimen-demonstrated-statistically-significant-improvement-in-overall-survival-in-previously-untreated-metastatic-pancreatic-ductal-adenocarcinoma-2/ 2022-11-09T06:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/Ipsen_Logo-7MlBm9.jpeg https://medicaex.com/businesswire/biomebank-announces-world-first-regulatory-approval-for-donor-derived-microbiome-drug/ 2022-11-09T06:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/BiomeBank-Logo-Horizontal-Colour-sfcwYT.jpeg https://medicaex.com/businesswire/onivyde-regimen-demonstrated-statistically-significant-improvement-in-overall-survival-in-previously-untreated-metastatic-pancreatic-ductal-adenocarcinoma/ 2022-11-09T06:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/Ipsen_Logo-oWQoaP.jpeg https://medicaex.com/businesswire/biote-reports-third-quarter-financial-results/ 2022-11-08T22:12:17+00:00 https://medicaex.com/businesswire/zymeworks-provides-corporate-update-and-reports-third-quarter-2022-financial-results-2/ 2022-11-08T22:12:16+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo-vljLSr.jpeg https://medicaex.com/businesswire/perimeter-medical-imaging-ai-announces-conference-call-and-webcast-to-discuss-third-quarter-2022-financial-results-and-provide-corporate-update-2/ 2022-11-08T22:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/Perimeter_Logo_Horizontal_FullColor-285rZQ.jpeg https://medicaex.com/businesswire/atlanticus-reports-third-quarter-2022-financial-results/ 2022-11-08T22:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/ATLC_Atlanticus_Logo-rLc1hd.jpeg https://medicaex.com/businesswire/masimo-reports-third-quarter-2022-financial-results-3/ 2022-11-08T22:12:13+00:00 https://medicaex.com/businesswire/oscar-health-announces-results-for-third-quarter-2022/ 2022-11-08T22:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/Oscar_Logo_Blue-Rn4f8F.jpeg https://medicaex.com/businesswire/perimeter-medical-imaging-ai-announces-conference-call-and-webcast-to-discuss-third-quarter-2022-financial-results-and-provide-corporate-update/ 2022-11-08T22:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Perimeter_Logo_Horizontal_FullColor-GrVBeX.jpeg https://medicaex.com/businesswire/greenbrook-tms-reports-third-quarter-operational-and-financial-results-2/ 2022-11-08T22:12:10+00:00 https://medicaex.com/businesswire/masimo-reports-third-quarter-2022-financial-results-2/ 2022-11-08T22:12:10+00:00 https://medicaex.com/businesswire/greenbrook-tms-reports-third-quarter-operational-and-financial-results/ 2022-11-08T22:12:05+00:00 https://medicaex.com/businesswire/zymeworks-provides-corporate-update-and-reports-third-quarter-2022-financial-results/ 2022-11-08T22:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo-ce6Ece.jpeg https://medicaex.com/businesswire/evolus-reports-third-quarter-2022-results-and-provides-business-update-2/ 2022-11-08T22:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/LOGO-LsAayM.jpeg https://medicaex.com/businesswire/revance-reports-third-quarter-2022-financial-results-provides-corporate-update/ 2022-11-08T21:12:22+00:00 https://medicaex.com/businesswire/adicet-reports-third-quarter-2022-financial-results-and-provides-business-updates-2/ 2022-11-08T21:12:22+00:00 https://medicaex.com/wp-content/uploads/2022/11/adicet_logo_500x300_2800229_2800429-0IeHLk.jpeg https://medicaex.com/businesswire/abcellera-reports-q3-2022-business-results-3/ 2022-11-08T21:12:22+00:00 https://medicaex.com/wp-content/uploads/2022/11/AbCellera_Full_Colour_RGB_1-22IgQV.jpeg https://medicaex.com/businesswire/frequency-therapeutics-provides-business-updates-and-third-quarter-2022-financial-results-2/ 2022-11-08T21:12:22+00:00 https://medicaex.com/businesswire/evolus-reports-third-quarter-2022-results-and-provides-business-update/ 2022-11-08T21:12:22+00:00 https://medicaex.com/wp-content/uploads/2022/11/LOGO-WEBrh3.jpeg https://medicaex.com/businesswire/senseonics-holdings-inc-reports-third-quarter-2022-financial-results-2/ 2022-11-08T21:12:18+00:00 https://medicaex.com/wp-content/uploads/2022/11/SENS_logo-m2HJRJ.jpeg https://medicaex.com/businesswire/performant-financial-corporation-announces-financial-results-for-third-quarter-2022/ 2022-11-08T21:12:18+00:00 https://medicaex.com/wp-content/uploads/2022/11/Performant_Logo_Full_Color-04dRzV.jpeg https://medicaex.com/businesswire/abcellera-reports-q3-2022-business-results-2/ 2022-11-08T21:12:17+00:00 https://medicaex.com/wp-content/uploads/2022/11/AbCellera_Full_Colour_RGB_1-rTyNOX.jpeg https://medicaex.com/businesswire/tandem-diabetes-care-announces-upcoming-conference-presentation-3/ 2022-11-08T21:12:17+00:00 https://medicaex.com/wp-content/uploads/2022/11/2022_02_01_Tandem_Horizontal_Logo_New_RGB-reVLWD.jpeg https://medicaex.com/businesswire/model-n-announces-fourth-quarter-and-fiscal-year-2022-financial-results/ 2022-11-08T21:12:17+00:00 https://medicaex.com/wp-content/uploads/2022/11/Model_N_Logo-w3Jkfv.jpeg https://medicaex.com/businesswire/ichor-holdings-ltd-announces-third-quarter-2022-financial-results/ 2022-11-08T21:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/New_ichor_logo_2018_1-oOvTnt.jpeg https://medicaex.com/businesswire/electromed-inc-announces-fiscal-2023-first-quarter-results-2/ 2022-11-08T21:12:14+00:00 https://medicaex.com/businesswire/outset-medical-reports-third-quarter-2022-financial-results/ 2022-11-08T21:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/Outset-ID-OrangeGrey-wxxO68.jpeg https://medicaex.com/businesswire/tandem-diabetes-care-announces-upcoming-conference-presentation-2/ 2022-11-08T21:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/2022_02_01_Tandem_Horizontal_Logo_New_RGB-BpXp4Y.jpeg https://medicaex.com/businesswire/senseonics-holdings-inc-reports-third-quarter-2022-financial-results/ 2022-11-08T21:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/SENS_logo-Va7u7Z.jpeg https://medicaex.com/businesswire/electromed-inc-announces-fiscal-2023-first-quarter-results/ 2022-11-08T21:12:11+00:00 https://medicaex.com/businesswire/masimo-reports-third-quarter-2022-financial-results/ 2022-11-08T21:12:11+00:00 https://medicaex.com/businesswire/abcellera-reports-q3-2022-business-results/ 2022-11-08T21:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/AbCellera_Full_Colour_RGB_1-fqBvJn.jpeg https://medicaex.com/businesswire/frequency-therapeutics-provides-business-updates-and-third-quarter-2022-financial-results/ 2022-11-08T21:12:07+00:00 https://medicaex.com/businesswire/tandem-diabetes-care-announces-upcoming-conference-presentation/ 2022-11-08T21:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/2022_02_01_Tandem_Horizontal_Logo_New_RGB-1kAUdW.jpeg https://medicaex.com/businesswire/adicet-reports-third-quarter-2022-financial-results-and-provides-business-updates/ 2022-11-08T21:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/adicet_logo_500x300_2800229_2800429-lnGBlW.jpeg https://medicaex.com/businesswire/goodrx-reports-third-quarter-2022-results-2/ 2022-11-08T21:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/GoodRx_logo-4Lxb7M.jpeg https://medicaex.com/businesswire/goodrx-reports-third-quarter-2022-results/ 2022-11-08T21:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/GoodRx_logo-wIa71g.jpeg https://medicaex.com/businesswire/innovative-remote-health-monitoring-platform-ironrod-health-receives-growth-investment-from-hcap-partners-2/ 2022-11-08T20:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/IronRod_Tombstone-gs17RE.jpeg https://medicaex.com/businesswire/modmed-expands-its-marketing-services-to-providers-in-nine-additional-specialties-2/ 2022-11-08T20:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/PR-AMP-2022-Press-Release_1_2x-800x420-12LIpp.jpeg https://medicaex.com/businesswire/innovative-remote-health-monitoring-platform-ironrod-health-receives-growth-investment-from-hcap-partners/ 2022-11-08T20:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/IronRod_Tombstone-gwZY6j.jpeg https://medicaex.com/businesswire/modmed-expands-its-marketing-services-to-providers-in-nine-additional-specialties/ 2022-11-08T20:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/PR-AMP-2022-Press-Release_1_2x-800x420-RDMulM.jpeg https://medicaex.com/businesswire/life-line-screening-launches-at-home-lab-tests-private-and-convenient-health-tests-delivered-to-your-home-5/ 2022-11-08T18:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/MicrosoftTeams-image-9UWtcy.jpeg https://medicaex.com/businesswire/parse-biosciences-to-participate-in-canaccord-genuity-investor-conference/ 2022-11-08T18:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/Parse_FullLogo_RGB_Purple-KeNC1k.jpeg https://medicaex.com/businesswire/life-line-screening-launches-at-home-lab-tests-private-and-convenient-health-tests-delivered-to-your-home-3/ 2022-11-08T18:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/MicrosoftTeams-image-s96x8W.jpeg https://medicaex.com/businesswire/life-line-screening-launches-at-home-lab-tests-private-and-convenient-health-tests-delivered-to-your-home-2/ 2022-11-08T18:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/MicrosoftTeams-image-jDrEJj.jpeg https://medicaex.com/businesswire/medication-adherence-global-market-report-2022-increasingly-poor-adherence-to-prescribed-medication-boosting-demand-researchandmarkets-com/ 2022-11-08T18:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-VZHslj.jpeg https://medicaex.com/businesswire/life-line-screening-launches-at-home-lab-tests-private-and-convenient-health-tests-delivered-to-your-home/ 2022-11-08T18:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/MicrosoftTeams-image-VJYhr0.jpeg https://medicaex.com/businesswire/maat-pharma-reports-cash-and-revenues-for-third-quarter-2022-2/ 2022-11-08T17:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/Nov_2018_new_version_MaaT_Pharma_logo-YDRqy6.jpeg https://medicaex.com/businesswire/poxel-provides-corporate-update-and-reports-cash-and-revenue-for-the-third-quarter-and-nine-months-2022-2/ 2022-11-08T17:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo_Without_Background-I8TmLy.jpeg https://medicaex.com/businesswire/systemic-lupus-erythematosus-sle-update-bulletin-2022-gain-insights-on-the-latest-events-happening-in-the-treatment-landscape-researchandmarkets-com-2/ 2022-11-08T17:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-ad5MxU.jpeg https://medicaex.com/businesswire/ixlayer-taps-industry-veteran-alecia-pritchett-as-chief-growth-officer-2/ 2022-11-08T17:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/ixlayer-alecia-pritchett-v3_28129-6reQd4.jpeg https://medicaex.com/businesswire/enrollme-by-sureco-boosts-employee-satisfaction-and-resolves-management-inefficiencies-for-karmacheck-2/ 2022-11-08T17:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Enrollme-logo-color-I76JTR.jpeg https://medicaex.com/businesswire/maat-pharma-reports-cash-and-revenues-for-third-quarter-2022/ 2022-11-08T17:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/Nov_2018_new_version_MaaT_Pharma_logo-YWbF1c.jpeg https://medicaex.com/businesswire/poxel-provides-corporate-update-and-reports-cash-and-revenue-for-the-third-quarter-and-nine-months-2022/ 2022-11-08T17:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo_Without_Background-xczGlM.jpeg https://medicaex.com/businesswire/systemic-lupus-erythematosus-sle-update-bulletin-2022-gain-insights-on-the-latest-events-happening-in-the-treatment-landscape-researchandmarkets-com/ 2022-11-08T17:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-DGOW2M.jpeg https://medicaex.com/businesswire/enrollme-by-sureco-boosts-employee-satisfaction-and-resolves-management-inefficiencies-for-karmacheck/ 2022-11-08T17:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Enrollme-logo-color-UyTgYG.jpeg https://medicaex.com/businesswire/ixlayer-taps-industry-veteran-alecia-pritchett-as-chief-growth-officer/ 2022-11-08T17:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/ixlayer-alecia-pritchett-v3_28129-3UaNNt.jpeg https://medicaex.com/businesswire/bayer-signs-grant-agreement-to-advance-research-in-non-hormonal-contraception-2/ 2022-11-08T16:12:18+00:00 https://medicaex.com/wp-content/uploads/2022/11/Bayer_Logo-1lWmCu.jpeg https://medicaex.com/businesswire/yonalink-raises-6m-in-funding-to-scale-global-growth-and-fuel-expansion-of-platform-designed-to-stream-clinical-trial-data-2/ 2022-11-08T16:12:18+00:00 https://medicaex.com/wp-content/uploads/2022/11/Yonalink-Logo-BK1jQh.jpeg https://medicaex.com/businesswire/global-wellness-technology-company-sensate-names-maryellen-gleason-as-chair-of-the-board-of-directors-2/ 2022-11-08T16:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/Maryellen-Gleason-pic-31IVCk.jpeg https://medicaex.com/businesswire/global-organ-preservation-market-report-2022-rising-focus-on-patient-engagement-and-advantages-of-crm-software-boosting-growth-researchandmarkets-com/ 2022-11-08T16:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-6EWe7s.jpeg https://medicaex.com/businesswire/global-wellness-technology-company-sensate-names-maryellen-gleason-as-chair-of-the-board-of-directors/ 2022-11-08T16:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/Maryellen-Gleason-pic-cULpMF.jpeg https://medicaex.com/businesswire/pharmajet-needle-free-system-selected-to-deliver-intradermal-polio-vaccine-in-nigerian-campaign-2/ 2022-11-08T16:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/Photo_for_PharmaJet_Nigeria_SIA_press_release-NnX5yE.jpeg https://medicaex.com/businesswire/pharmajet-needle-free-system-selected-to-deliver-intradermal-polio-vaccine-in-nigerian-campaign/ 2022-11-08T16:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Photo_for_PharmaJet_Nigeria_SIA_press_release-rukNYU.jpeg https://medicaex.com/businesswire/arctaris-announces-bank-of-america-as-investor-in-new-25m-regional-opportunity-zone-program-focused-on-diversity-equity-inclusion-and-community-revitalization/ 2022-11-08T16:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Arctaris_Impact_Investors_Logo_RGB-qYmGoK.jpeg https://medicaex.com/businesswire/yonalink-raises-6m-in-funding-to-scale-global-growth-and-fuel-expansion-of-platform-designed-to-stream-clinical-trial-data/ 2022-11-08T16:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/Yonalink-Logo-9zlu2g.jpeg https://medicaex.com/businesswire/global-nephroblastoma-treatment-market-report-2022-increasing-rd-activities-driving-sector-growth-researchandmarkets-com/ 2022-11-08T16:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-OeRglt.jpeg https://medicaex.com/businesswire/2022-global-prostate-cancer-clinical-trial-pipeline-highlights-report-track-competition-identify-partners-and-evaluate-opportunities-researchandmarkets-com/ 2022-11-08T16:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-CvEDA5.jpeg https://medicaex.com/businesswire/bayer-signs-grant-agreement-to-advance-research-in-non-hormonal-contraception/ 2022-11-08T16:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Bayer_Logo-Z0o3UP.jpeg https://medicaex.com/businesswire/wolters-kluwer-strengthens-clinical-surveillance-portfolio-with-sentri7-sepsis-monitor-3/ 2022-11-08T15:12:16+00:00 https://medicaex.com/wp-content/uploads/2022/11/WK_Logo-UZyhDw.jpeg https://medicaex.com/businesswire/sustained-patient-response-to-krystexxa-pegloticase-injection-with-methotrexate-compared-to-krystexxa-alone-shown-through-month-12-in-mirror-randomized-controlled-trial-2/ 2022-11-08T15:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/Horizon_Logo_Full-Color_RGB_Registered_Logo-dDp4UQ.jpeg https://medicaex.com/businesswire/nucleai-expands-scientific-advisory-board-with-oncology-industry-luminary-dr-julian-adams-2/ 2022-11-08T15:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/Dr._Adams-iSJUjH.jpeg https://medicaex.com/businesswire/immunotek-plasma-adds-second-location-in-indiana/ 2022-11-08T15:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/9J6A1361-rcQ1eG.jpeg https://medicaex.com/businesswire/immune-onc-therapeutics-appoints-two-new-members-to-its-board-of-directors-2/ 2022-11-08T15:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/Imune-Onc_Theraputics_Logo_Square-8OHJ0x.jpeg https://medicaex.com/businesswire/distributed-ventures-announces-new-hires-to-leadership-and-investment-team/ 2022-11-08T15:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/download-1-iV2zFz.jpeg https://medicaex.com/businesswire/hurons-katie-clarke-named-consulting-magazine-2022-woman-leader-in-consulting/ 2022-11-08T15:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/Huron_2022_Logo-75kh1h.jpeg https://medicaex.com/businesswire/wolters-kluwer-strengthens-clinical-surveillance-portfolio-with-sentri7-sepsis-monitor-2/ 2022-11-08T15:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/WK_Logo-eTpFLL.jpeg https://medicaex.com/businesswire/middle-east-africa-diagnostic-labs-market-report-2022-next-generation-tech-including-machine-learning-and-ai-leads-to-sector-growth-researchandmarkets-com/ 2022-11-08T15:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-6XJ5VP.jpeg https://medicaex.com/businesswire/mindmaze-partners-with-mount-sinai-health-system-to-pioneer-a-digital-neurotherapeutic-program-to-improve-patient-outcomes-in-the-clinic-and-at-home/ 2022-11-08T15:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/MindMaze-Logo-K-Pos-aHt68M.jpeg https://medicaex.com/businesswire/advanced-wound-care-management-global-market-report-2022-increase-in-volume-of-surgical-procedures-worldwide-driving-growth-researchandmarkets-com-2/ 2022-11-08T15:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-xtl2NF.jpeg https://medicaex.com/businesswire/creakyjoints-presents-multistakeholder-priorities-for-research-in-vaccine-uptake-among-adults-with-autoimmune-disease-at-the-american-college-of-rheumatology-convergence-2022-2/ 2022-11-08T15:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo_CJ_720_IDEAL_Business_Wire-zzNpGu.jpeg https://medicaex.com/businesswire/wolters-kluwer-strengthens-clinical-surveillance-portfolio-with-sentri7-sepsis-monitor/ 2022-11-08T15:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/WK_Logo-VVmPq8.jpeg https://medicaex.com/businesswire/advanced-wound-care-management-global-market-report-2022-increase-in-volume-of-surgical-procedures-worldwide-driving-growth-researchandmarkets-com/ 2022-11-08T15:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-iy2wTi.jpeg https://medicaex.com/businesswire/creakyjoints-presents-multistakeholder-priorities-for-research-in-vaccine-uptake-among-adults-with-autoimmune-disease-at-the-american-college-of-rheumatology-convergence-2022/ 2022-11-08T15:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo_CJ_720_IDEAL_Business_Wire-aJQ1WP.jpeg https://medicaex.com/businesswire/the-worldwide-ocular-adhesives-sealants-industry-is-expected-to-reach-376-7-million-by-2027-researchandmarkets-com/ 2022-11-08T15:12:09+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-v0H7jt.jpeg https://medicaex.com/businesswire/barbados-prime-minister-mia-amor-mottley-announces-transatlantic-bridge-between-the-caribbean-latin-america-and-africa-to-develop-and-manufacture-pharmaceuticals-for-global-public-health/ 2022-11-08T15:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo-GBP9Un.jpeg https://medicaex.com/businesswire/codetta-biosciences-and-north-carolina-central-university-receive-2m-grant-from-the-north-carolina-collaboratory/ 2022-11-08T15:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/Codetta_Logo_with_tagline-XQaLJP.jpeg https://medicaex.com/businesswire/sustained-patient-response-to-krystexxa-pegloticase-injection-with-methotrexate-compared-to-krystexxa-alone-shown-through-month-12-in-mirror-randomized-controlled-trial/ 2022-11-08T15:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Horizon_Logo_Full-Color_RGB_Registered_Logo-Nw6GZg.jpeg https://medicaex.com/businesswire/nucleai-expands-scientific-advisory-board-with-oncology-industry-luminary-dr-julian-adams/ 2022-11-08T15:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Dr._Adams-EaLRVE.jpeg https://medicaex.com/businesswire/immune-onc-therapeutics-appoints-two-new-members-to-its-board-of-directors/ 2022-11-08T15:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Imune-Onc_Theraputics_Logo_Square-GdNsKd.jpeg https://medicaex.com/businesswire/reimagine-care-and-the-center-for-cancer-blood-disorders-announce-partnership-3/ 2022-11-08T14:12:16+00:00 https://medicaex.com/wp-content/uploads/2022/11/ReimagineCare_Logo_2Clr-Wph2OU.jpeg https://medicaex.com/businesswire/livanova-to-present-at-the-stifel-wolfe-and-piper-sandler-healthcare-conferences-2/ 2022-11-08T14:12:16+00:00 https://medicaex.com/wp-content/uploads/2022/11/LN-Logo-Main-PANTONE-Z97Gi7.jpeg https://medicaex.com/businesswire/combinostics-adds-industry-experts-to-leadership-team/ 2022-11-08T14:12:16+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo_Combinostics_FullColor-O4qfPV.jpeg https://medicaex.com/businesswire/ndds-easyone-air-tested-to-new-depths-in-worlds-largest-freediving-competition-2/ 2022-11-08T14:12:16+00:00 https://medicaex.com/wp-content/uploads/2022/11/2201NDD08Nov_Freediver_Gary_McGrath_and_EasyOne_Air-4zUYoJ.jpeg https://medicaex.com/businesswire/unitvisid-leads-growing-rfid-use-in-healthcare-with-rebrand-4/ 2022-11-08T14:12:16+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo-TZGg7J.jpeg https://medicaex.com/businesswire/relias-launches-competency-evaluations/ 2022-11-08T14:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Relias_logo-aq0IPw.jpeg https://medicaex.com/businesswire/empiricalab-selected-to-techstars-workforce-development-accelerator/ 2022-11-08T14:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/9xZ5VXs4_400x400-FfV18s.jpeg https://medicaex.com/businesswire/reimagine-care-and-the-center-for-cancer-blood-disorders-announce-partnership-2/ 2022-11-08T14:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/ReimagineCare_Logo_2Clr-0J99N1.jpeg https://medicaex.com/businesswire/eclinicalworks-cloud-reduces-costs-by-50-for-hyndman-area-health-center/ 2022-11-08T14:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/eclinicalworks-logo-white-Mz4d60.jpeg https://medicaex.com/businesswire/pointclickcare-announces-real-world-data-collaboration-with-pfizer-2/ 2022-11-08T14:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/PointClickCareLogoCMYK-rnV9TH.jpeg https://medicaex.com/businesswire/unitvisid-leads-growing-rfid-use-in-healthcare-with-rebrand-3/ 2022-11-08T14:12:11+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo-PhJUAW.jpeg https://medicaex.com/businesswire/omnivision-announces-first-miniature-2-megapixel-cmos-image-sensor-in-square-format-for-disposable-and-reusable-endoscopes/ 2022-11-08T14:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/1-OH02B10-paperclip-hluke8.jpeg https://medicaex.com/businesswire/livanova-to-present-at-the-stifel-wolfe-and-piper-sandler-healthcare-conferences/ 2022-11-08T14:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/LN-Logo-Main-PANTONE-S4cmRa.jpeg https://medicaex.com/businesswire/successful-first-in-human-clinical-study-of-kardiums-next-generation-globe-pulsed-field-system-2/ 2022-11-08T14:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/Globe_PF_System_EP_Lab-1SvoHx.jpeg https://medicaex.com/businesswire/ndds-easyone-air-tested-to-new-depths-in-worlds-largest-freediving-competition/ 2022-11-08T14:12:10+00:00 https://medicaex.com/wp-content/uploads/2022/11/2201NDD08Nov_Freediver_Gary_McGrath_and_EasyOne_Air-d86OAU.jpeg https://medicaex.com/businesswire/successful-first-in-human-clinical-study-of-kardiums-next-generation-globe-pulsed-field-system/ 2022-11-08T14:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Globe_PF_System_EP_Lab-rVnVLI.jpeg https://medicaex.com/businesswire/unitvisid-leads-growing-rfid-use-in-healthcare-with-rebrand-2/ 2022-11-08T14:12:08+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo-QcvC3f.jpeg https://medicaex.com/businesswire/triclabendazole-global-market-report-2022-featuring-advacare-pharma-rv-lifesciences-grampus-laboratories-intas-pharmaceuticals-shanghai-tongren-pharmaceutical-more-researchandmarkets-com/ 2022-11-08T14:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-1AiVbt.jpeg https://medicaex.com/businesswire/unitvisid-leads-growing-rfid-use-in-healthcare-with-rebrand/ 2022-11-08T14:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/Logo-gjX0Rm.jpeg https://medicaex.com/businesswire/mediprint-ophthalmics-announces-it-has-initiated-its-sight-2-phase-2b-clinical-study-for-its-lead-asset/ 2022-11-08T14:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/MediPrint_Ophthalmics_logo_new_3.15.21-A2uy4M.jpeg https://medicaex.com/businesswire/blue-earth-therapeutics-awarded-uk-mhra-innovation-passport-for-investigational-177lu-rhpsma-10-1-for-treatment-of-metastatic-castrate-resistant-prostate-cancer-mcrpc/ 2022-11-08T14:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/BET_logo-Omz0eB.jpeg https://medicaex.com/businesswire/pointclickcare-announces-real-world-data-collaboration-with-pfizer/ 2022-11-08T14:12:05+00:00 https://medicaex.com/wp-content/uploads/2022/11/PointClickCareLogoCMYK-MKk4YV.jpeg https://medicaex.com/businesswire/reimagine-care-and-the-center-for-cancer-blood-disorders-announce-partnership/ 2022-11-08T14:12:03+00:00 https://medicaex.com/wp-content/uploads/2022/11/ReimagineCare_Logo_2Clr-q5gbX7.jpeg https://medicaex.com/businesswire/pipeline-therapeutics-to-present-multiple-posters-at-sfn-2022-neuroscience-annual-meeting-2/ 2022-11-08T13:12:19+00:00 https://medicaex.com/businesswire/apnimed-to-present-at-the-stifel-healthcare-conference-2/ 2022-11-08T13:12:19+00:00 https://medicaex.com/wp-content/uploads/2022/11/Apnimed_logo-QAp8vp.jpeg https://medicaex.com/businesswire/scholar-rock-to-participate-in-upcoming-investor-conferences-2/ 2022-11-08T13:12:19+00:00 https://medicaex.com/wp-content/uploads/2022/11/Scholar_Rock_Logo-cIWxgD.jpeg https://medicaex.com/businesswire/aviceda-announces-additional-world-class-members-to-its-clinical-advisory-board-to-support-its-clinical-development-strategy-in-ophthalmology-2/ 2022-11-08T13:12:18+00:00 https://medicaex.com/wp-content/uploads/2022/11/AVICEDA_THERAPEUTICS_LOGO_MASTER-pQj4FI.jpeg https://medicaex.com/businesswire/worldwide-bone-cement-industry-to-2027-heightening-applications-of-bone-cement-in-the-healthcare-industry-to-improve-the-recovery-of-patients-is-aiding-growth-researchandmarkets-com/ 2022-11-08T13:12:18+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-Met2VQ.jpeg https://medicaex.com/businesswire/ionpath-showcases-real-time-spatial-phenotyping-using-mibi-spatial-proteomics-technology-at-the-annual-meeting-of-the-society-for-immunotherapy-of-cancer-2/ 2022-11-08T13:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/IONpath_Logo-3vPWde.jpeg https://medicaex.com/businesswire/novo-integrated-sciences-subsidiary-clinical-consultants-international-signs-sales-consulting-agreement-with-smart-healthcare-solution-provider-tiatech-usa-inc-2/ 2022-11-08T13:12:15+00:00 https://medicaex.com/wp-content/uploads/2022/11/For_PRs_NVOS_Logo_28640x36029-37GPmP.jpeg https://medicaex.com/businesswire/heather-bender-joins-healthedge-as-chief-people-officer/ 2022-11-08T13:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/HeatherBender-TKr9Yy.jpeg https://medicaex.com/businesswire/care-angel-and-upside-partner-to-offer-ai-driven-housing-and-sdoh-benefit-to-health-insurers/ 2022-11-08T13:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/CareAngel_graphic-Upside_white-FmlCgK.jpeg https://medicaex.com/businesswire/simbiosys-inc-awarded-2m-phase-ii-nci-sbir-contract-to-support-the-development-of-its-multi-scale-platform-for-spatial-tumor-visualization-and-analysis/ 2022-11-08T13:12:14+00:00 https://medicaex.com/wp-content/uploads/2022/11/SimBioSys_Logo-v0XjWC.jpeg https://medicaex.com/businesswire/cardio-diagnostics-holdings-inc-sponsors-beckers-hospital-review-11th-annual-meeting-the-ceo-cfo-roundtable/ 2022-11-08T13:12:13+00:00 https://medicaex.com/wp-content/uploads/2022/11/mc_110322_highres1_28129-piBtzd.jpeg https://medicaex.com/businesswire/first-ever-future-of-pregnancy-health-report-reveals-9-out-of-10-new-or-expecting-moms-want-more-information-about-their-individual-risk-of-pregnancy-complications-to-optimize-preven/ 2022-11-08T13:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/Mirvie_Logo_2021-pfSsUs.jpeg https://medicaex.com/businesswire/bioaffinity-technologies-to-report-third-quarter-2022-financial-results/ 2022-11-08T13:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/bioAfinity_logo-S7mF7i.jpeg https://medicaex.com/businesswire/the-worldwide-cryogenic-equipment-industry-is-expected-to-reach-36-7-billion-by-2030-researchandmarkets-com/ 2022-11-08T13:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/logo-6pWtpO.jpeg https://medicaex.com/businesswire/atricure-to-present-at-34th-annual-piper-sandler-healthcare-conference/ 2022-11-08T13:12:12+00:00 https://medicaex.com/wp-content/uploads/2022/11/AtriCure_logo_1-color_RBG_Web_010218-gB8y7k.jpeg https://medicaex.com/businesswire/ionpath-showcases-real-time-spatial-phenotyping-using-mibi-spatial-proteomics-technology-at-the-annual-meeting-of-the-society-for-immunotherapy-of-cancer/ 2022-11-08T13:12:07+00:00 https://medicaex.com/wp-content/uploads/2022/11/IONpath_Logo-MxCT4G.jpeg https://medicaex.com/businesswire/aviceda-announces-additional-world-class-members-to-its-clinical-advisory-board-to-support-its-clinical-development-strategy-in-ophthalmology/ 2022-11-08T13:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/AVICEDA_THERAPEUTICS_LOGO_MASTER-NWnCtY.jpeg https://medicaex.com/businesswire/pipeline-therapeutics-to-present-multiple-posters-at-sfn-2022-neuroscience-annual-meeting/ 2022-11-08T13:12:06+00:00 https://medicaex.com/businesswire/apnimed-to-present-at-the-stifel-healthcare-conference/ 2022-11-08T13:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Apnimed_logo-km6v9p.jpeg https://medicaex.com/businesswire/scholar-rock-to-participate-in-upcoming-investor-conferences/ 2022-11-08T13:12:06+00:00 https://medicaex.com/wp-content/uploads/2022/11/Scholar_Rock_Logo-czbvgz.jpeg https://medicaex.com/businesswire/novo-integrated-sciences-subsidiary-clinical-consultants-international-signs-sales-consulting-agreement-with-smart-healthcare-solution-provider-tiatech-usa-inc/ 2022-11-08T13:12:04+00:00 https://medicaex.com/wp-content/uploads/2022/11/For_PRs_NVOS_Logo_28640x36029-eKKOlv.jpeg https://medicaex.com/businesswire/precision-biosciences-reports-third-quarter-2022-financial-results-and-provides-business-update-2/ 2022-11-08T12:12:18+00:00 https://medicaex.com/wp-content/uploads/2022/11/Precision_BioSciences_logo-0rIrJG.jpeg